Amifampridine is a pyridine diamine derivative that functions as an acetylcholine release enhancer, indicated for the symptomatic treatment of Lambert-Eaton myasthenic syndrome in adults. This category… Read more
Amifampridine is a pyridine diamine derivative that functions as an acetylcholine release enhancer, indicated for the symptomatic treatment of Lambert-Eaton myasthenic syndrome in adults. This category provides a comprehensive selection of high-quality compounds required for robust pharmaceutical analysis, including the active pharmaceutical ingredient (API) reference standard, related synthetic impurities, and stable isotope labelled compounds. Laboratories utilize these materials for impurity profiling, method validation, and rigorous quality control testing to ensure the safety and efficacy of final drug products. By incorporating stable isotope labelled standards, such as 3,4-diaminopyridine-d3, researchers can achieve greater precision in mass spectrometry-based assays. Whether conducting stability studies or routine potency testing, analysts rely on these rigorously characterized reference standards to identify pharmacopeial and non-pharmacopeial impurities, such as specific diaminopyridine derivatives, ensuring consistent compliance with strict regulatory standards throughout the drug development lifecycle.